Mike Cavanaugh
Speaker Host, Investillations
Replay available
NANO-X IMAGING LTD (NASDAQ: NNOX) Q3 2025 earnings conference call, held 2025-11-20. Replay captured from the company's public earnings webcast.

Speaker Host, Investillations
Chief Financial Officer
Chief Executive Officer & Acting Chairman
Watch the replay and follow the connected company analysis, news, and investor updates for Nano-x Imaging Ltd.
WEBVTT 00:00:00.031 -- 00:00:06.196 We're standing by. Welcome to NADOC's third quarter 2025 earnings conference call. 00:00:06.196 -- 00:00:08.999 At this time, all participants are on a listen-only mode. 00:00:08.999 -- 00:00:12.482 After the speaker's presentation, there will be a question and answer session. 00:00:12.482 -- 00:00:16.445 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:16.445 -- 00:00:19.868 You will then hear an automated message advising your hand is raised. 00:00:19.868 -- 00:00:23.390 Please note today's conference is being recorded. 00:00:24.692 -- 00:00:29.397 I will now hand the conference over to your speaker host, Mike Cavanaugh of Investillations. 00:00:29.397 -- 00:00:31.797 Please go ahead. 00:00:32.279 -- 00:00:37.546 Good morning and welcome to the Nanox Imaging third quarter 2025 investor call. 00:00:37.546 -- 00:00:42.372 Earlier today, Nanox Imaging Limited released financial results for the quarter ending 00:00:42.372 -- 00:00:44.973 September 30, 2025. 00:00:45.136 -- 00:00:49.822 The release is currently available on the investor section of the company's website. 00:00:49.822 -- 00:00:54.889 With me today are Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ron 00:00:54.889 -- 00:00:57.895 Daniel, Chief Financial Officer. 00:00:57.895 -- 00:01:01.258 Before we get started, I would like to remind everyone that management will be making 00:01:01.258 -- 00:01:06.423 statements during this call that include forward-looking statements regarding the company's 00:01:06.423 -- 00:01:11.969 financial results, research and development, manufacturing and commercialization activities, 00:01:11.969 -- 00:01:16.914 regulatory process and clinical activities, and other matters. 00:01...